Other genes whose overexpression was associated with poor survival of breast and prostate cancer patients encode regulators of differentiation (ROD1), protein kinases (MAPK4), and regulators of cytoskeletal organisation (TMSB10, Figure 5C). This evidence concerns the gene WEE1 and prostate carcinoma.